Clinical Relevance and Prevalence of Polymorphisms in CYP3A5 and MDR1 Genes That Encode Tacrolimus Biotransformation Enzymes in Liver Transplant Recipients-Reference-Cited by-同舟云学术

Clinical Relevance and Prevalence of Polymorphisms in CYP3A5 and MDR1 Genes That Encode Tacrolimus Biotransformation Enzymes in Liver Transplant Recipients

Published:2008-11 Issue:9 Volume:40 Page:2949-2951
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Barrera-Pulido L.,Aguilera-García I.,Docobo-Pérez F.,Álamo-Martínez J.M.,Pareja-Ciuró F.,Nuñez-Roldán A.,Gómez-Bravo M.A.,Bernardos-Rodríguez A.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference7 articles.

1. Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome P4503A5 and P-glycoprotein correlate with dose requirement;Macphee;Transplantation,2002

2. CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation;Goto;Pharmacogenetics,2004

3. Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation;Songfeng;Transplantation,2006

4. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression;Kuehl;Nat Genet,2001

5. Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene;Johne;Clin Pharmacol Ther,2002

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early impact of donor CYP3A5 genotype and Graft-to-Recipient Weight Ratio on tacrolimus pharmacokinetics in pediatric liver transplant patients;Scientific Reports;2021-01-11

2. Pharmaceutical care in transplantation: current challenges and future opportunities;Nanomedicine;2019-10

3. The impact of liver transplant recipient and donor genetic variability on tacrolimus exposure and transplant outcome;British Journal of Clinical Pharmacology;2019-07-24

4. Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant cases;Pharmacological Reports;2019-06

5. Effect of CYP3A5*1 expression on tacrolimus required dose after liver transplantation: A systematic review and meta-analysis;Clinical Transplantation;2018-06-21